Comparar métodos
Examine os métodos selecionados lado a lado; as linhas que diferem ficam destacadas.
| Escore CHA₂DS₂-VASc× | Pontuação APACHE II× | |
|---|---|---|
| Área | Avaliação clínica | Avaliação clínica |
| Família | Process / pipeline | Process / pipeline |
| Ano de origem≠ | 2010 | 1985 |
| Autor original≠ | Gregory Y. H. Lip, Robby Nieuwlaat, et al. | William A. Knaus, et al. |
| Tipo≠ | Atrial fibrillation stroke risk stratification | ICU severity and mortality prediction |
| Fonte seminal≠ | Lip, G. Y., Nieuwlaat, R., Pisters, R., Lane, D. A., & Crijns, H. J. (2010). Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. Chest, 137(2), 263-272. DOI ↗ | Knaus, W. A., Draper, E. A., Wagner, D. P., & Zimmerman, J. E. (1985). APACHE II: a severity of disease classification system. Critical Care Medicine, 13(10), 818-829. DOI ↗ |
| Outros nomes | CHA2DS2VASc, Atrial fibrillation stroke risk | APACHE-II, APACHE2 |
| Relacionados | 3 | 3 |
| Resumo≠ | The CHA₂DS₂-VASc score, developed by Lip, Nieuwlaat, and colleagues in 2010, is a 9-point risk stratification tool for predicting annual stroke and systemic thromboembolism risk in patients with atrial fibrillation. It is the recommended score by major cardiology guidelines for guiding anticoagulation decisions. | The Acute Physiology and Chronic Health Evaluation (APACHE) II score, introduced by Knaus et al. in 1985, is a 71-point severity of illness classification system for critically ill patients. It combines acute physiological parameters, age, and chronic health status to predict intensive care unit (ICU) mortality, facilitating patient risk stratification and research standardization. |
| ScholarGateConjunto de dados ↗ |
|
|